STEAP1 and pseudotumor cerebri: This high prevalence of IIH correlates with a recently published paper that reported an IIH prevalence of 32% and 36% based on PSMA- and STEAP1-positive or -negative immunostainings, respectively, after analysis on an average of only 3 samples per patient (27).